Citigroup Inc Dexcom Inc Transaction History
Citigroup Inc
- $163 Billion
- Q4 2024
A detailed history of Citigroup Inc transactions in Dexcom Inc stock. As of the latest transaction made, Citigroup Inc holds 1,198,702 shares of DXCM stock, worth $103 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
1,198,702
Previous 922,732
29.91%
Holding current value
$103 Million
Previous $61.8 Million
50.75%
% of portfolio
0.06%
Previous 0.04%
Shares
14 transactions
Others Institutions Holding DXCM
# of Institutions
1,084Shares Held
352MCall Options Held
8.45MPut Options Held
5.75M-
Vanguard Group Inc Valley Forge, PA46.5MShares$4 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2.97 Billion0.09% of portfolio
-
State Street Corp Boston, MA16.7MShares$1.43 Billion0.05% of portfolio
-
Baillie Gifford & CO14.6MShares$1.26 Billion0.9% of portfolio
-
Capital Research Global Investors Los Angeles, CA14.4MShares$1.24 Billion0.24% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $33.2B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...